Abstract
A Phase I dose escalation trial of motexafin gadolinium (gadolinium texaphyrin, xcytrin R)as a radiation sensitizer in patients with newly diagnosed glioblastoma multiforme
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
